- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.52 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x 4DZ: 2-(9-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)benzene-1,3-dicarbonitrile(Non-covalent)
- 3 x GSH: GLUTATHIONE(Non-covalent)
GSH.2: 13 residues within 4Å:- Chain A: R.66, N.70, E.73, H.109, Y.113, R.122, S.123, Y.126
- Chain B: A.27, T.30, R.34, L.65
- Ligands: 4DZ.1
13 PLIP interactions:7 interactions with chain A, 6 interactions with chain B- Hydrogen bonds: A:N.70, A:E.73, A:Y.113, A:Y.113, A:R.122
- Water bridges: A:N.70, A:Y.126, B:R.34, B:R.34, B:N.42, B:N.42, B:H.68
- Salt bridges: B:R.34
GSH.8: 13 residues within 4Å:- Chain B: R.66, N.70, E.73, H.109, Y.113, R.122, S.123, Y.126
- Chain C: A.27, T.30, R.34, L.65
- Ligands: 4DZ.7
13 PLIP interactions:7 interactions with chain B, 6 interactions with chain C- Hydrogen bonds: B:N.70, B:E.73, B:Y.113, B:Y.113, B:R.122
- Water bridges: B:N.70, B:Y.126, C:R.34, C:R.34, C:N.42, C:N.42, C:H.68
- Salt bridges: C:R.34
GSH.14: 13 residues within 4Å:- Chain A: A.27, T.30, R.34, L.65
- Chain C: R.66, N.70, E.73, H.109, Y.113, R.122, S.123, Y.126
- Ligands: 4DZ.13
13 PLIP interactions:6 interactions with chain A, 7 interactions with chain C- Water bridges: A:R.34, A:R.34, A:N.42, A:N.42, A:H.68, C:N.70, C:Y.126
- Salt bridges: A:R.34
- Hydrogen bonds: C:N.70, C:E.73, C:Y.113, C:Y.113, C:R.122
- 6 x BOG: octyl beta-D-glucopyranoside(Non-covalent)
BOG.3: 6 residues within 4Å:- Chain A: A.134, S.135, L.138, Q.139, W.142
- Ligands: PG4.5
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:A.134
- Hydrogen bonds: A:S.135, A:Q.139, A:W.142
- Water bridges: A:S.135, A:S.135
BOG.4: 8 residues within 4Å:- Chain A: K.22, V.25, I.29, T.110, L.114, G.115, K.116
- Ligands: PEG.6
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:K.22, A:V.25, A:I.29, A:T.110
- Hydrogen bonds: A:K.116
BOG.9: 6 residues within 4Å:- Chain B: A.134, S.135, L.138, Q.139, W.142
- Ligands: PG4.11
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:A.134
- Hydrogen bonds: B:S.135, B:Q.139, B:W.142
- Water bridges: B:S.135, B:S.135
BOG.10: 8 residues within 4Å:- Chain B: K.22, V.25, I.29, T.110, L.114, G.115, K.116
- Ligands: PEG.12
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:K.22, B:V.25, B:I.29, B:T.110
- Hydrogen bonds: B:K.116
BOG.15: 6 residues within 4Å:- Chain C: A.134, S.135, L.138, Q.139, W.142
- Ligands: PG4.17
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:A.134
- Hydrogen bonds: C:S.135, C:Q.139, C:W.142
- Water bridges: C:S.135, C:S.135
BOG.16: 8 residues within 4Å:- Chain C: K.22, V.25, I.29, T.110, L.114, G.115, K.116
- Ligands: PEG.18
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:K.22, C:V.25, C:I.29, C:T.110
- Hydrogen bonds: C:K.116
- 3 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
PG4.5: 5 residues within 4Å:- Chain A: M.97, H.98, P.132, S.135
- Ligands: BOG.3
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.135
PG4.11: 5 residues within 4Å:- Chain B: M.97, H.98, P.132, S.135
- Ligands: BOG.9
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:S.135
PG4.17: 5 residues within 4Å:- Chain C: M.97, H.98, P.132, S.135
- Ligands: BOG.15
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:S.135
- 3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.6: 4 residues within 4Å:- Chain A: D.60, R.63, L.114
- Ligands: BOG.4
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:D.60
PEG.12: 4 residues within 4Å:- Chain B: D.60, R.63, L.114
- Ligands: BOG.10
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.60
PEG.18: 4 residues within 4Å:- Chain C: D.60, R.63, L.114
- Ligands: BOG.16
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:D.60
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Luz, J.G. et al., Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics. J.Med.Chem. (2015)
- Release Date
- 2015-06-10
- Peptides
- Prostaglandin E synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.52 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x 4DZ: 2-(9-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)benzene-1,3-dicarbonitrile(Non-covalent)
- 3 x GSH: GLUTATHIONE(Non-covalent)
- 6 x BOG: octyl beta-D-glucopyranoside(Non-covalent)
- 3 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 3 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Luz, J.G. et al., Crystal Structures of mPGES-1 Inhibitor Complexes Form a Basis for the Rational Design of Potent Analgesic and Anti-Inflammatory Therapeutics. J.Med.Chem. (2015)
- Release Date
- 2015-06-10
- Peptides
- Prostaglandin E synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.